2 results
Approved WMOCompleted
To construct the utility surfaces of tapentadol and oxycodone.
Approved WMOWill not start
The purpose of this study is to evaluate the possible risks and efficacy (improvement of disease) with an experimental oral study drug named eliglustat in pediatric patients from 2 to 18 years with Gaucher disease.